test

Oncology

  • Cancer is the leading cause of mortality in the world. It is increasing the burden on the families and society.
  • Novel therapeutics are not being discovered at the pace equal to rate of cancer growth and resistance.
  • CaroCure is focused on developing innovative medicines targeting the growth and proliferation of cancer cells for which accessible treatments are insufficient.
  • Our molecules (FENTASTIC FIVE) are working effectively on Leukemia, Breast, Melanoma, Colon & Renal Cancer

Immuno-Oncology

  • CaroCure is a Pre-clinical stage company developing novel molecules that transform medicine by re-engaging the body’s immune system to treat cancer
  • We are unlocking the full potential of the immune system to recognize and attack cancer.
  • We are unlocking the full potential of the immune system to recognize and attack cancer.
  • We are unlocking the full potential of the immune system to recognize and attack cancer.
  • We are unlocking the full potential of the immune system to recognize and attack cancer.
  • We are unlocking the full potential of the immune system to recognize and attack cancer.

Cardiovascular Diseases

  • The progress of novel cardiovascular drugs is at its lowest point since many years.
  • Approvals by the agencies for new cardiovascular drugs have dropped melodramatically.
  • Big pharma have terminated many research activities in cardiology.
  • We in CaroCure are committed to work in this challenging area directly targeting Acute myocardial infarction (AMI), Hypercholesterolemia - coronary artery disease (CAD), Familial Hypercholesterolemia, Anti-inflammatory effect.
  • Lead molecules with high potency has reiterated the efficiency of the protocols developed in CaroCure.
General Information

Info@carocure.com

Job Inquiries

careers@carocure.com

Investors

investors@carocure.com

Media

media@carocure.com

Address
INDIA

IKP Knowledge Park Genome Valley, Hyderabad, India India

USA

2897 Churchhill Lane Saginaw MI 48603 USA.

Copy right 2019. CaroCure. All rights reserved.